Results 111 to 120 of about 26,893 (258)
Acneiform type of mogamulizumab‐associated rash
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Inga Hansen‐Abeck +5 more
wiley +1 more source
Cancer, Volume 131, Issue 13, 1 July 2025.Abstract Background Indoleamine 2,3‐dioxygenase 1 (IDO1) is a heme‐containing enzyme that degrades tryptophan (Trp) to kynurenine (Kyn), which suppresses effector T cells and reduces antitumor activity. KHK2455 is a long‐acting selective IDO1 inhibitor that blocks the heme component of the IDO holoenzyme.
Timothy A. Yap +16 more
wiley +1 more source
Misdiagnoses of Hair and Scalp Disorders in Adult Patients With Skin of Color
International Journal of Dermatology, EarlyView.
Eric McMullen +10 more
wiley +1 more source
CD70: An emerging target for integrated cancer diagnosis and therapy
Clinical and Translational Medicine, Volume 15, Issue 7, July 2025.CD70 is aberrantly overexpressed in diverse tumours with limited normal tissue expression, making it a compelling diagnostic and therapeutic target. Immuno‐PET/CT facilitates tumour detection, staging, and treatment monitoring. Multiple CD70‐targeted therapies are under early evaluation. Rational combination strategies are emerging to enhance antitumor
Jiatao Hu +9 more
wiley +1 more source
A CASE OF MYCOSIS FUNGOIDES SUCCESSFULLY TREATED BY THE X RAYS. [PDF]
, 1906 G. G. S. Taylor
openalex +1 more source
Phototherapy of Mycosis Fungoides
Dermatologic Clinics, 2015 Therapies based on ultraviolet light have long been established in mycosis fungoides (MF). They have traditionally included whole-body ultraviolet light B, both broad-band and narrow-band, and psoralen plus ultraviolet A. Phototherapy may be applied alone in early stage MF or in combination with systemic therapy in refractory early stage MF and ...
Emmilia Hodak, Lev Pavlovsky
openaire +3 more sources
Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance [PDF]
, 2019 Sézary syndrome (SS) is a rare and aggressive variant of Cutaneous T-Cell Lymphoma characterized by neoplastic distribution mainly involving blood, skin, and lymph-node.
Benucci, Roberto +15 more
core +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 7, Page 822-830, July 2025.Summary Background Primary cutaneous B cell lymphomas (CBCL) are chronic diseases with frequent relapses. Time to next treatment (TTNT) is an endpoint reflecting clinical benefit of treatments including patient perspectives. The objectives were to evaluate clinical characteristics, survival, prognosis and TTNT in CBCL.
Rohat Cankaya +6 more
wiley +1 more source